Levosalbutamol PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Levosalbutamol PCD pharma franchise company offering a portfolio of 23 Levosalbutamol formulations. We supply quality-assured, consistently manufactured Levosalbutamol products to franchise partners and distributors across India on a monopoly (district-wise) basis.

What is Levosalbutamol?

Levosalbutamol (levalbuterol) is the active R-enantiomer of salbutamol and a short-acting beta-2 adrenergic agonist that relaxes bronchial smooth muscle to relieve airway narrowing. It is used to treat and prevent bronchospasm in asthma and chronic obstructive pulmonary disease (COPD). Reference: PubChem.

Available Forms

Our Levosalbutamol range is available as Capsule, Drop, Inhaler, Rota Cap, Syrup and Tablets, allowing partners to serve diverse prescriptions from a single reliable supplier.

Therapeutic Applications of Levosalbutamol

Levosalbutamol is indicated for the relief and prevention of bronchospasm in bronchial asthma, COPD and other reversible obstructive airway diseases. It is commonly prescribed by pulmonologists, paediatricians, chest physicians and general physicians.

Why Levosalbutamol is a High-Potential Molecule for Distributors

Respiratory disease is one of India’s largest and fastest-growing therapy segments, driven by rising asthma, COPD and pollution-related airway conditions. With 23 formulations spanning paediatric drops and syrups, inhalers, rota caps and tablets, Levosalbutamol lets distributors serve every prescriber and age group, ensuring broad reach and chronic repeat demand.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent pricing and dependable supply chain help distributors build a profitable long-term business.

References

1. PubChem - Levosalbutamol
2. DrugBank - Levalbuterol
3. PubMed - Levosalbutamol research